Rights and permissions
About this article
Cite this article
First-line tapentadol cost effective for severe chronic pain. Pharmacoecon. Outcomes News 650, 8 (2012). https://doi.org/10.2165/00151234-201206500-00022
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201206500-00022